Allspring Global Investments Holdings LLC Buys 53,186 Shares of The Clorox Company (NYSE:CLX)

Allspring Global Investments Holdings LLC boosted its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 19.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 329,271 shares of the company's stock after buying an additional 53,186 shares during the period. Allspring Global Investments Holdings LLC owned about 0.27% of Clorox worth $46,951,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. International Assets Investment Management LLC increased its holdings in shares of Clorox by 3,665.3% in the 4th quarter. International Assets Investment Management LLC now owns 102,718 shares of the company's stock valued at $14,647,000 after purchasing an additional 99,990 shares during the period. Valley National Advisers Inc. increased its holdings in shares of Clorox by 458.3% in the 4th quarter. Valley National Advisers Inc. now owns 268 shares of the company's stock valued at $38,000 after purchasing an additional 220 shares during the period. Prime Capital Investment Advisors LLC increased its holdings in shares of Clorox by 18.2% in the 4th quarter. Prime Capital Investment Advisors LLC now owns 3,317 shares of the company's stock valued at $473,000 after purchasing an additional 511 shares during the period. Sowell Financial Services LLC increased its holdings in shares of Clorox by 2.0% in the 4th quarter. Sowell Financial Services LLC now owns 20,232 shares of the company's stock valued at $2,885,000 after purchasing an additional 399 shares during the period. Finally, Arizona State Retirement System grew its stake in shares of Clorox by 1.0% in the 4th quarter. Arizona State Retirement System now owns 34,081 shares of the company's stock valued at $4,860,000 after buying an additional 354 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on CLX shares. Morgan Stanley reissued an "equal weight" rating and issued a $160.00 price target on shares of Clorox in a research note on Tuesday, March 26th. Barclays decreased their target price on Clorox from $148.00 to $136.00 and set an "underweight" rating for the company in a research report on Wednesday. Citigroup reaffirmed a "neutral" rating and set a $165.00 target price (down previously from $170.00) on shares of Clorox in a research report on Tuesday, April 2nd. DA Davidson reiterated a "neutral" rating and set a $162.00 price target on shares of Clorox in a report on Monday, February 5th. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $145.00 to $152.00 and gave the stock a "neutral" rating in a report on Thursday, January 18th. Four equities research analysts have rated the stock with a sell rating and twelve have issued a hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $149.13.

Clorox Stock Performance

CLX traded down $2.82 during trading on Friday, hitting $141.98. The stock had a trading volume of 685,065 shares, compared to its average volume of 1,218,812. The firm has a market cap of $17.62 billion, a price-to-earnings ratio of 229.84, a P/E/G ratio of 2.25 and a beta of 0.43. The company has a debt-to-equity ratio of 11.37, a current ratio of 0.89 and a quick ratio of 0.57. The company has a 50 day moving average price of $151.48 and a 200-day moving average price of $141.29. The Clorox Company has a one year low of $114.68 and a one year high of $178.21.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. The firm had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company's quarterly revenue was up 16.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.98 EPS. As a group, research analysts predict that The Clorox Company will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be issued a $1.20 dividend. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.38%. Clorox's dividend payout ratio is presently 761.92%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.